Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Lisdexamfetamine 💬
(Lisdexamfetamine (INN))
[1] Lisdexamfetamine (Lisdexamfetamine dimesylate)[0] [2] SLC6A2,
SLC6A3 💬
[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬-
2 Lisdexamfetamine dimesylate 💬
(Lisdexamfetamine dimesylate (USAN), Lisdexamfetamine mesilate (JAN), LISDEXAMFETAMINE DIMESYLATE)
[1] Lisdexamfetamine (Lisdexamfetamine dimesylate)[0] [2] SLC6A2,
SLC6A3 💬
[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬-